Pancreaticopleural fistula is an extremely rare complication of chronic pancreatitis. Interestingly it may present without any symptoms of pancreatitis per se. The diagnosis requires a high index of suspicion due to the predominant thoracic symptoms. Cases with massive, rapidly refilling, refractory pleural effusion in the setting of pancreatitis (symptomatic or asymptomatic) should be suspected of having a pancreaticopleural fistula. We report two cases of pancreaticopleural fistula. One of the patient also had pancreatic divisum and to the best of our knowledge this is the first case report of pancreatic divisum with pancreaticopleural fistula in the literature.
Introduction
Pancreatitis can present with various complications, but rarely without the symptoms of pancreatitis per se. Pancreaticopleural fistula (PPF) is one such complication, seen more commonly with chronic than acute pancreatitis. It is seen in 0.4% of patients with pancreatitis. 1 PPF and pancreatic ascites are internal pancreatic fistulas, a term coined by Cameron et al. 2 PPF presents as massive pleural effusion. The predominant thoracic symptoms cause a delay in the diagnosis. It is different from the pleural effusion of acute pancreatitis. 3 We describe two patients with PPF. Neither had been previously diagnosed with chronic pancreatitis. Both had dyspnea and chest pain due to massive pleural effusion. Evaluation showed very high pleural fluid amylase levels. Endoscopic retrograde cholangiopancreatography (ERCP) diagnosed leak in one patient. Magnetic Resonance cholangiopancreatography (MRCP) diagnosed leak in the other patient.
Medical therapy failed in both. ERCP was successful in one but failed in other patient, who was managed surgically. Both the patients were asymptomatic on follow up after 1 year.
Case Report #1
A 50 years old gentleman presented with right sided chest pain, cough and progressive dyspnea since one month. There was history of 40 gm/day of alcohol intake for last 15 years. Patient had undergone pleural fluid tapping twice without relief.
On examination, he had fever, tachypnea, tachycardia, pallor, edema feet, ascites and right sided pleural effusion.
His hemoglobin was 6 gm%, WBC count -25,900/cu.mm. Albumin was 2.1gm% with normal liver enzymes. Serum amylase was 1284 IU/L (0-96). Ascitic fluid amylase was 52 IU/L. Pleural fluid WBC was 864 cells/cu.mm, protein (3.9 gm%), normal adenosine deaminase level and very high amylase of 39,440 IU/L, suggestive of PPF. Chest X ray showed massive right sided pleural effusion and mediastinal shift. His CT scan of the abdomen showed chronic calcific pancreatitis with dilated pancreatic duct (PD). His MRCP showed chronic pancreatitis with suspected leak in the body of pancreas. Patient underwent ERCP due to poor response to octreotide and intercostal drain and MRCP findings. Pancreatogram ( Figure 1 ) revealed a dilated irregular PD with multiple calculi and mid body leak communicating with the right pleural cavity. Pancreatic sphincterotomy with stone extraction and PD stenting was done. Following this patient recovered completely and was discharged after 1 month.
Case Report #2
A 28 years old gentleman, presented with left sided chest pain and progressive dyspnea since 3 months, without any abdominal complaints. There was history of consumption of 40 grams per day of alcohol for 8 years. On examination he had tachypnea and left sided pleural effusion. Chest Xray showed massive left sided pleural effusion. Pleural fluid examination showed WBC -972/cu.mm, protein -3.0 gms%, amylase 26,491 IU/L (0-180 IU/L) and normal adenosine deaminase. Serum amylase was normal. His MRCP (Figure 2 ) showed moderate to severe left pleural effusion (arrow), a 3.3×2.8×1.4 sized collection left of GE junction (arrow), extending into abdominal cavity through esophageal hiatus communicating with the left pleural cavity.
Another small collection in the peri-pancreatic region superior to neck of pancreas (arrow), communicating with MPD(arrow), close to the collection near GE junction was seen. Minimal irregular dilatation of PD. Type II pancreatic divisum was also seen. PD drained in the minor papilla and CBD into the major papilla. ERCP (Figure 3 ) with minor papilla cannulation with pancreatogram showed complete cut off at the genu. Minor papillotomy was done. Patient had no improvement with medical treatment and ERCP. He underwent distal pancreatectomy with splenectomy. Following surgery patient had good recovery and was discharged after 5 weeks.
Discussion
Pleural effusion in acute pancreatitis is seen in 3-7% of patients. 4 However, pleural effusion due to PPF is seen in less than 1% of cases, suggesting its rare occurrence. 5 Cameron et al suggested that if PD ruptures posteriorly, it leads to mediastinal pseudocysts and pancreaticopleural fistula. 6 Pancreatic pseudocysts are seen in 43-79% of patients with PPF. 1,7-9 One of our patient had peri-pancreatic collection but no pseudocyst. The most common presenting complaint is dyspnea (65-76%). 8, 9 Pleural effusion is left sided (42-67%), right-sided (19-40%) or even bilateral (14-17%). 1, 8, 9, 10 Males in mid-forties with a history of chronic alcoholism and previous episodes of pancreatitis (none of our patient had) form the classical description of PPF. Chronic Pancreatitis related to alcohol abuse (67%) is the most common cause in adults, 11 while biliary duct obstruction in children. 12 Pleural fluid amylase is the diagnostic test. There is no established threshold for amylase, but it is significantly elevated (>1000 U/L), with mean levels above 10,000 U/L. 1, 8, 9, 13 CT, ERCP and MRCP are used for imaging and delineating the fistula.
The sensitivity in detecting PPF is 47%, 78% and 80% respectively. 8, 14 MRCP is the imaging modality of choice. It is noninvasive and visualizes fistula beyond strictures. It gives details of pancreatic parenchymal and ductal structural changes. This helps in planning of intervention, endoscopic or surgical. 15 PPF can be treated with conservative (medical and endoscopic) or surgical method. Failure of resolution or development of complications are indications for endoscopic or surgical intervention. 1, 13 Medical treatment comprises chest drainage and octreotide administration. 16 Patients with normal or mildly dilated PD and no strictures are candidates for medical therapy. Its success rate is 31-65%. 1, 8, 9, 15 ERCP is used as therapeutic modality because it is invasive and can cause complications like infection, pancreatitis, bleeding and perforation. 13 ERCP is indicated for ductal disruptions in the head or body and a stricture downstream to the disruption. Stent placement should decompress PD. It should also preferably bridge the site of ductal disruption. The optimal duration for stent is around 4-12 weeks. 7, 13, 16, 17 It was successful in one of our patient. Surgery is used after failure of medical and endoscopic therapy. Indications are complete ductal obstruction, leak in the pancreatic tail, a downstream stricture that cannot be stented, or if the site of ductal disruption cannot be bridged by a stent. 13 The operation performed commonly is distal pancreatectomy, followed by pancreaticojejunostomy. 8 One patient was treated surgically. Also this patient had pancreatic divisum. To the best of our knowledge this is the first case report in the literature of divisum with PPF. However as this patient was also alcoholic, divisum alone cannot be attributed as the cause of chronic pancreatitis.
Conclusions
Pancreaticopleural fistula is a rare complication of pancreatitis. Predominant thoracic symptoms make diagnosis challenging. Awareness of the entity helps in early diagnosis and appropriate treatment.
Patients not responding to conservative treatment should undergo endoscopic or surgical therapy. Pancreatic divisum in association with other known etiologies of pancreatitis may lead to not just chronic pancreatitis but also its complications like pancreaticopleural fistula.
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